Offer - Urjas Oil for just ₹ 1
Telmikaa Am is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Telmikaa Am have also been mentioned below.
The right dosage of Telmikaa Am depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Telmikaa Am include Headache, Dizziness, Palpitations (fluttering in chest). Apart from the aforementioned side effects, Telmikaa Am can also lead to other problems, which have been listed below. Such side effects of Telmikaa Am normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Telmikaa Am is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Telmikaa Am related warnings talks about Telmikaa Am's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Congestive Heart Failure (CHF), Coronary Artery Disease (CAD), Angioedema must refrain from the use of Telmikaa Am since this can cause severe adverse effects.
Drug reaction of Telmikaa Am with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Telmikaa Am, it is important to know that it is not safe while driving, and is not habit-forming.
Telmikaa Am is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Telmikaa Am safe for pregnant women?
Telmikaa Am shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Telmikaa Am safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Telmikaa Am. So it is adviced to consult the doctor before using it.
What is the effect of Telmikaa Am on the Kidneys?
Telmikaa Am may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Telmikaa Am on the Liver?
There may be an adverse effect on the liver after taking Telmikaa Am. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Telmikaa Am on the Heart?
Telmikaa Am may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Telmikaa Am should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Telmikaa Am unless your doctor advises you to do so -
Is this Telmikaa Am habit forming or addictive?
No, there is no any evidence that Telmikaa Am is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Telmikaa Am. So it is best to avoid driving.
Is it safe?
Yes, but consume Telmikaa Am only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Telmikaa Am for mental disorders.
Interaction between Food and Telmikaa Am
Due to a lack of research, nothing can be said about the consequences of taking Telmikaa Am together with food.
Interaction between Alcohol and Telmikaa Am
Due to lack of research, there is no information about the side effects of taking Telmikaa Am with alcohol.
No, Telmikaa Am doesn't cause a headache. However, if you experience a headache while using Telmikaa Am, please consult your doctor without any delay.
No, Telmikaa Am is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Telmikaa Am is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telmikaa Am might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telmikaa Am exactly as prescribed by their doctor.
No, Telmikaa Am doesn't cause depression. However, if you experience depression while taking Telmikaa Am, please talk to your doctor immediately.
No, Telmikaa Am does not cause weight gain. Weight gain has rarely been associated with this drug. However, if you are experiencing unusual weight gain and you are in doubt that Telmikaa Am is causing weight gain then discuss with your doctor instantly.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
